Latest News

Latest News

News from the World Hepatitis Alliance

VACANCY: FUNDRAISING AND BUSINESS DEVELOPMENT MANAGER

23 Nov 2020 Tina Kasap

2 part time or 1 full time post DEADLINE: 12 noon GMT, Friday 4 December...

Nominate your regional board member

9 Nov 2020 Chris Wingrove

2020 is an election year. The time has come again for WHA members to have a say about who is representing them at a regional level. Three new board...

Vacancy: Events Manager

22 Oct 2020 Chris Wingrove

Do you have the passion, drive and commitment to deliver inspiring and unique event experiences? An exciting opportunity has arisen for an...

WHA statement: scientists who discovered hepatitis C virus awarded Nobel Prize

5 Oct 2020 Lucy Ferrier

On the announcement of the Nobel Prize in Physiology or Medicine 2020 being awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice...

WHA is looking for skilled and creative freelancers

25 Sep 2020 Lucy Ferrier

The World Hepatitis Alliance is currently searching for skilled, creative and free-thinking freelancers to support the organisation’s fight against...

Vacancy: Communications Manager

24 Sep 2020 Chris Wingrove

DEADLINE FOR APPLICATIONS: 5 OCTOBER It is an exciting time to be joining the World Hepatitis Alliance (WHA), we are about to embark on a new five-...

Celebrating World Hepatitis Day: hepVoice July/August 2020 out now

18 Aug 2020 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + WHA members shine on World Hepatitis Day;
 + hepinion: Why we need World Hepatitis Day now...

A message from WHA President, Dr Su Wang

29 Jul 2020 Chris Wingrove

World Hepatitis Day 2020 is an important landmark for the hepatitis community. We are now just ten years away from the 2030 elimination targets set...

WHA launches new report on World Hepatitis Day: Developing an HCV Investment Case for Punjab (India)

24 Jul 2020 Lucy Ferrier

On World Hepatitis Day (28 July) 2020, the World Hepatitis Alliance (WHA), in partnership with the Ministry of Health in India Punjab State and the Clinton Health Access Initiative (CHAI), is pleased to launch a new report: Developing an HCV Investment Case for Punjab (India)...

World Hepatitis Day webinar series

26 Jun 2020 Chris Wingrove

Our webinar series explores key issues in global hepatitis elimination. Each webinar will bring together an expert panel of speakers to share their...

hepVoice May/June is out now

25 Jun 2020 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + WHA members inspire during COVID-19 pandemic;
 + New World Hepatitis Day website and...

Urge your government to keep their promise to eliminate viral hepatitis

18 Jun 2020 Lucy Ferrier

Support NOhep's World Hepatitis Day open letter campaign to urge your government to stand by their commitment to eliminate viral hepatitis....

New World Hepatitis Day website and campaign materials launched

9 Jun 2020 Lucy Ferrier

We have launched a brand new website and campaign materials for the 2020 World Hepatitis Day campaign...

We're hiring: Project Coordinator (Maternity Cover - 15 months)

1 Jun 2020 Chris Wingrove

About the World Hepatitis Alliance Alongside our 290+ member organisations working on the ground in 94 countries, the World Hepatitis Alliance...

World Hepatitis Alliance submits written intervention ahead of 73rd World Health Assembly

20 May 2020 Lucy Ferrier

Ahead of the 73rd World Health Assembly, WHA submitted a written intervention, which drew on findings from our global COVID-19 survey, to highlight the impact of COVID-19 on people living with viral hepatitis and on hepatitis services....

hepVoice March/April is out now

1 Apr 2020 Lucy Ferrier

The latest issue of hepVoice is out now. In this issue: + COVID-19 message from WHA President, Su Wang;
 + New partnership to eliminate hepatitis C...

COVID-19. Information for people living with viral hepatitis

31 Mar 2020 Chris Wingrove

During the COVID-19 pandemic, the World Hepatitis Alliance (WHA) is committed to bringing you the most up to date information for people living with...

COVID-19 message from World Hepatitis Alliance president, Su Wang

25 Mar 2020 Lucy Ferrier

know the WHA family of members around the world will make it through this crisis together....

WHA features in Your Liver campaign

17 Mar 2020 Chris Wingrove

WHA recently worked with Health Awareness on the 2020 Your Liver campaign. A printed publication was enclosed within every copy of the Guardian...

Message from Su Wang, World Hepatitis Alliance President

16 Mar 2020 Chris Wingrove

Dear Colleagues, It is my honour to take up the role of President of the World Hepatitis Alliance (WHA) this year. It is a privilege to represent...

Pages

News from infohep

Few countries will meet 2020 target for reducing viral hepatitis deaths

24 Nov 2020 Keith Alcorn
Around 1.1 million deaths were caused by viral hepatitis worldwide in 2019 and deaths due to hepatitis C are still rising despite the availability of...

Some hepatitis B patients can safely stop antivirals

24 Nov 2020 Liz Highleyman
Many people who take nucleoside/nucleotide antivirals for chronic hepatitis B can safely discontinue treatment, although this usually does not lead...

Can investment in hepatitis C treatment be cost saving?

24 Nov 2020 Keith Alcorn
Direct-acting antiviral treatment for hepatitis C can be cost saving for some countries within five to ten years, especially if they can negotiate...

Tenofovir alafenamide prevents mother-to-child hepatitis B virus transmission

20 Nov 2020 Liz Highleyman
Tenofovir alafenamide (TAF; Vemlidy) is highly effective at preventing transmission of hepatitis B virus (HBV) from mothers with a high viral load to...

Minimal monitoring of hepatitis C treatment is safe and effective

17 Nov 2020 Keith Alcorn
Hepatitis C treatment with no monitoring visits during treatment is safe and leads to a high cure rate, an international study reported on Monday at...

NASVAC therapeutic vaccine may lead to functional cure of hepatitis B

17 Nov 2020 Liz Highleyman
NASVAC, an experimental therapeutic vaccine that targets two different hepatitis B virus (HBV) antigens, led to a reduction in hepatitis B surface...

Fatty liver greatly increases vulnerability to COVID-19 in obese people

16 Nov 2020 Keith Alcorn
Fatty liver disease combined with obesity places people at much higher risk of severe COVID-19, analysis of British people who tested positive for...

Which people with chronic liver disease have higher COVID-19 risks?

16 Nov 2020 Keith Alcorn
Decompensated cirrhosis, alcoholic liver disease and hepatocellular carcinoma each raise the risk of death and severe illness from COVID-19 among...

Peers of drug users play key roles in hepatitis C treatment decision-making

4 Nov 2020 Keith Alcorn
Peers are important sources of information about hepatitis C treatment and may be the most persuasive advocates for engaging with treatment and care...

Cotadutide improves metabolic and liver biomarkers in people with NAFLD and diabetes

26 Oct 2020 Liz Highleyman
Cotadutide, an experimental therapy that alters glucose and lipid metabolism, led to weight loss and improvements in metabolic, cardiovascular and...